Legal & General Group
SQZ

Legal & General Group’s SQZ Biotechnologies Company SQZ Stock Holding History

Legal & General Group’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,817
Closed -$9K – 3725
2022
Q1 		$9K Hold
1,817
– – ﹤0.01% 3438
2021
Q4 		$16K Hold
1,817
– – ﹤0.01% 3356
2021
Q3 		$26K Hold
1,817
– – ﹤0.01% 3190
2021
Q2 		$26K Buy
1,817
+1,378
+314% +$18K ﹤0.01% 3199
2021
Q1 		$6K Hold
439
– – ﹤0.01% 3470
2020
Q4 		$13K Buy
+439
New +$11.2K ﹤0.01% 3258

Other funds holding SQZ

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
N
NanoDimension Woodside, California $24.7M AUM 74.01% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Legal & General Group's SQZ Position: Q2 2022 in Review

Legal & General Group sold out of SQZ Biotechnologies Company (SQZ) in Q2 2022, closing a stake of 1,817 shares — an estimated $9K sold.

Legal & General Group first reported a position in SQZ in Q4 2020 and held it in 6 quarters. The position peaked at $26K in Q3 2021. 53 funds tracked by Wall St. Rank hold SQZ as of Q2 2022.

  • Legal & General Group reported no remaining SQZ Biotechnologies Company position as of Q2 2022 after selling out during the quarter.
  • Legal & General Group sold 1,817 SQZ Biotechnologies Company shares in Q2 2022, an estimated $9K.
  • Legal & General Group first reported a position in SQZ Biotechnologies Company in Q4 2020 and held it in 6 quarters.
  • Legal & General Group's SQZ Biotechnologies Company position peaked at $26K in Q3 2021.
  • 53 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q2 2022.

Based on Legal & General Group's 13F filing for Q2 2022, filed 22 Aug 2022.